Clinuvel Pharmaceuticals Ltd (CLVLY)
8.95
+0.01
(+0.11%)
USD |
OTCM |
Nov 13, 16:00
Clinuvel Pharmaceuticals Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| December 31, 2023 | 0.006 |
| June 30, 2023 | 0.00 |
| December 31, 2022 | 0.0082 |
| June 30, 2022 | 0.00 |
| December 31, 2021 | 0.0109 |
| June 30, 2021 | 0.00 |
| December 31, 2020 | 0.0176 |
| June 30, 2020 | 0.00 |
| December 31, 2019 | 0.0053 |
| June 30, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| June 30, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| June 30, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| June 30, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2020
0.0176
Maximum
Dec 2020
0.0048
Average
0.0027
Median
Debt to Equity Ratio Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Opthea Ltd | -1.867 |
| Mesoblast Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 154.48M |
| Total Liabilities (Quarterly) | 18.79M |
| Shareholders Equity (Quarterly) | 135.69M |
| Current Ratio | 8.808 |
| Net Debt Paydown Yield | 0.05% |